treatment of wounds
healing of skin wounds
treatment of chronic wounds
close wounds
Exo-Wound
problem of chronic wounds
place Exogenus
successful commercialisation Exogenus
advanced wound care market
better efficacy
competitive position
cells
healing capacity
treatment duration
Healing Exosomes
company
patients
new therapeutic tool
stimulation of skin growth
new solutions
standard care
Cell therapies
project objectives
global commercialization
market entrance
swift product development
promising therapeutic strategies
global healthcare systems
fast growing segment of active therapies
important improvements
high demand
Europe
promotion of vascularisation
severe cost burden
classic
Umbilical Cord Blood
necessary activities
need of partnerships
UCB
biocompatibility
factors
limited engraftment
ideal funding vehicle
animal models
significant business opportunity
late stages of human trials
SME instrument
capital
clinical validation
safety
Valley of death
gap
Results
survival
order
humans
reported cases
competition
years
accomplishment
revenues
spin
diabetic ulcers